Two studies by the IDIBAPS IMARD group, listed in the top twelve articles published by the journal Molecular Psychiatry in 2022
The papers, to which Joaquim Raduà and Miquel A. Fullana contributed, were awarded first and third places on the list.
The papers, to which Joaquim Raduà and Miquel A. Fullana contributed, were awarded first and third places on the list.
Researchers from the Hospital Clínic-IDIBAPS, IDIBELL and CIBERSAM have developed a smartphone app that allows anxiety to be assessed continuously an1
The finding may make it possible to take therapeutic approaches that will increase the success rate of cognitive-behavioral therapy. This is the ther1